Martina Mambrini
Overview
Explore the profile of Martina Mambrini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vincenzi E, Fantazzini A, Basso C, Barla A, Odone F, Leo L, et al.
Respir Res
. 2022 Nov;
23(1):308.
PMID: 36369209
Idiopathic pulmonary fibrosis, the archetype of pulmonary fibrosis (PF), is a chronic lung disease of a poor prognosis, characterized by progressively worsening of lung function. Although histology is still the...
2.
Khalajzeyqami Z, Grandi A, Ferrini E, Ravanetti F, Leo L, Mambrini M, et al.
PLoS One
. 2022 Jun;
17(6):e0270005.
PMID: 35704641
Idiopathic pulmonary fibrosis (IPF) is a progressive disease with no curative pharmacological treatment. The most used animal model of IPF for anti-fibrotic drug screening is bleomycin (BLM)-induced lung fibrosis. However,...
3.
Mambrini M, Mecozzi L, Ferrini E, Leo L, Bernardi D, Grandi A, et al.
Sci Rep
. 2022 Jun;
12(1):9695.
PMID: 35690601
Micro-computed tomography (CT) imaging provides densitometric and functional assessment of lung diseases in animal models, playing a key role either in understanding disease progression or in drug discovery studies. The...
4.
Mecozzi L, Mambrini M, Ruscitti F, Ferrini E, Ciccimarra R, Ravanetti F, et al.
Sci Rep
. 2020 Oct;
10(1):18735.
PMID: 33127949
Although increasing used in the preclinical testing of new anti-fibrotic drugs, a thorough validation of micro-computed tomography (CT) in pulmonary fibrosis models has not been performed. Moreover, no attempts have...